JPRN-UMIN000036157招募中未知
A phase II study of mFOLFOX6 after exposure to Nivolumab in advanced gastric cancer - A phase II study of mFOLFOX6 after exposure to Nivolumab in advanced gastric cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe complications 2) With active infection 3) Past history of severe hypersensitivity to drugs 4) Pregnant women, or women with the possibility of the pregnancy, Men who want let to pregnancy 5) Patients judged inappropriate for the study by the physicians
研究者
相似试验
招募中
2 期
A phase II study of mFOLFOX6+Nivolumab in gastric cancer with severe peritoneal metastasisgastric cancerJPRN-jRCTs041220164Masuishi Toshiki55
招募中
2 期
Phase2 study of mFOLFOX6 plus nivolumab for patients with ESCCEsophageal CancerJPRN-jRCTs031230630Kubota Yohei33
已完成
2 期
Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.Colorectal CancerJPRN-UMIN000001490Yakult Honsha Co.,Ltd.65
已完成
2 期
Randomized phase II study of mFOLFOX6 versus TS-1/CPT-11 in patients with advanced/recurrent colorectal cancerPatients with advanced and/or recurrent colorectal cancerJPRN-UMIN000000786OGSG70
已完成
2 期
Randomized phase 2 study of mFOLFOX6 plus bevacizumab versus modified OPTIMOX plus bevacizumab for metastatic colorectal cancercolorectal cancerJPRN-UMIN000003477Chiba Cancer Center Hospital80